Eton Pharmaceuticals (ETON) Gross Profit (2019 - 2025)

Eton Pharmaceuticals has disclosed Gross Profit across 7 years of filings, most recently posting $13.1 million for Q4 2025.

• Gross Profit for Q4 2025 came in at $13.1 million, up 102.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $42.7 million (up 82.56% YoY), and the FY2025 annual result was $42.7 million, up 82.56% from the prior year.
• Gross Profit came in at $13.1 million for Q4 2025 at Eton Pharmaceuticals, up from $7.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $13.1 million in Q4 2025 to a low of $121000.0 in Q3 2021.
• The 5-year median for Gross Profit is $5.7 million (2021), against an average of $6.0 million.
• Across the five-year window, Gross Profit jumped 343666.67% in 2021 and tumbled 87.13% in 2022, its largest moves.
• Eton Pharmaceuticals' Gross Profit stood at $5.7 million in 2021, then increased by 11.17% to $6.4 million in 2022, then sank by 42.92% to $3.6 million in 2023, then jumped by 78.4% to $6.5 million in 2024, then soared by 102.29% to $13.1 million in 2025.
• The last three Gross Profit figures came in at $13.1 million (Q4 2025), $7.9 million (Q3 2025), and $11.9 million (Q2 2025), per Business Quant data.